Historical record - last NADAC effective date: 1/4/2017
Product Information
DUETACT 30-2 MG TABLET is a brand product labeled by Takeda Pharmaceuticals America, Inc., priced at $19.1240 per EA under NDC 64764030230. Its NADAC has been published 216 times since Nov 28, 2013.
FDA first approved this application on Jul 28, 2006. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
Strength
2; 30 mg/1; mg/1
Manufacturer
Takeda Pharmaceuticals America, Inc.NDC
64764030230
Classification
Brand
Dosage Form
TABLET
Route
ORAL
Effective Date
1/4/2017
Active Ingredients
GLIMEPIRIDE; PIOGLITAZONE HYDROCHLORIDEApproval Type
New Drug (NDA)
FDA Application
NDA021925FDA Approved
7/28/2006
TE Code
AB
On Market Since
7/28/2006
Pharmacological Classes
Price Statistics
The NADAC for DUETACT 30-2 MG TABLET has been published 216 times since Nov 28, 2013, and over the history we have for it it has risen 65.1%. The table below summarizes its recorded NADAC range and movement.
| Current price | $19.1240 per EA |
|---|---|
| All-time high | $19.1240 (Jan 10, 2018) |
| All-time low | $11.5811 (Nov 28, 2013) |
| Median price | $16.8942 |
| Average price | $16.4359 |
| Largest weekly change | +9.9% (Jan 14, 2015) |
| Weeks tracked | 216 |
| Tracking since | Nov 28, 2013 |
1W
N/A
1M
N/A
3M
N/A
6M
N/A
1Y
N/A
3Y
N/A
5Y
N/A
All
+65.1%
Last surveyed Jan 10, 2018 — this NDC no longer appears in the current weekly NADAC file.
Generic Alternatives
The matcher finds 1 manufacturer offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 44% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Frequently asked questions
What is the NADAC price of DUETACT 30-2 MG TABLET?
The current National Average Drug Acquisition Cost (NADAC) for DUETACT 30-2 MG TABLET, manufactured by Takeda Pharmaceuticals America, Inc., is $19.1240 per EA (NDC 64764030230), effective Jan 10, 2018.
How has the price of DUETACT 30-2 MG TABLET changed over time?
Over the history we have for it, the NADAC for DUETACT 30-2 MG TABLET has risen 65.1%. It has been tracked across 216 weekly CMS publications since Nov 28, 2013.
What are the highest and lowest recorded NADAC prices for DUETACT 30-2 MG TABLET?
Since Nov 28, 2013, the NADAC for DUETACT 30-2 MG TABLET has ranged from a low of $11.5811 (Nov 28, 2013) to a high of $19.1240 (Jan 10, 2018), with a median of $16.8942 per EA.
Are there cheaper alternatives to DUETACT 30-2 MG TABLET?
Yes. 1 manufacturer publishes a NADAC-priced product with the same active ingredient and strength in a comparable dosage form. The lowest-priced option, PIOGLITAZONE-GLIMEPIRIDE 30-2, is $10.7597 per EA — about 44% below DUETACT 30-2 MG TABLET.
Who manufactures DUETACT 30-2 MG TABLET?
DUETACT 30-2 MG TABLET (NDC 64764030230) is labeled by Takeda Pharmaceuticals America, Inc., and CMS classifies it as a brand product.